Ian Ellis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hamilton L J; Evans A J; Cornford E J; Rakha E A; Ellis I O; Foulkes W D
Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?
Doyle Sarah; Evans Andrew J; Rakha Emad A; Green Andrew R; Ellis Ian O
Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening.
Au-Yong I T H; Evans A J; Taneja S; Rakha E A; Green A R; Paish C; Ellis I O
Sonographic correlations with the new molecular classification of invasive breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ian Ellis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hamilton L J; Evans A J; Cornford E J; Rakha E A; Ellis I O; Foulkes W D
Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?
Clinical radiology 2009;64(11):1045-7.
2009: Doyle Sarah; Evans Andrew J; Rakha Emad A; Green Andrew R; Ellis Ian O
Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening.
Radiology 2009;253(1):51-5.
2009: Au-Yong I T H; Evans A J; Taneja S; Rakha E A; Green A R; Paish C; Ellis I O
Sonographic correlations with the new molecular classification of invasive breast cancer.
European radiology 2009;19(10):2342-8.
2009: Foulkes William D; Grainge Matthew J; Rakha Emad A; Green Andrew R; Ellis Ian O
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status.
Breast cancer research and treatment 2009;117(1):199-204.
2009: Paish E C; Green A R; Rakha E A; Macmillan R D; Maddison J R; Ellis I O
Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth.
Journal of clinical pathology 2009;62(7):617-23.
2009: Rakha E A; Aleskandarany M; El-Sayed M E; Blamey R W; Elston C W; Ellis I O; Lee A H S
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
European journal of cancer (Oxford, England : 1990) 2009;45(10):1780-7.
2009: Mohammed R A A; Ellis I O; Lee A H S; Martin S G
Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms.
Histopathology 2009;55(1):1-9.
2009: Khoshnaw S M; Green A R; Powe D G; Ellis I O
MicroRNA involvement in the pathogenesis and management of breast cancer.
Journal of clinical pathology 2009;62(5):422-8.
2009: Elsheikh Somaia E; Green Andrew R; Rakha Emad A; Powe Des G; Ahmed Rabab A; Collins Hilary M; Soria Daniele; Garibaldi Jonathan M; Paish Claire E; Ammar Amr A; Grainge Matthew J; Ball Graham R; Abdelghany Magdy K; Martinez-Pomares Luisa; Heery David M; Ellis Ian O
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Cancer research 2009;69(9):3802-9.
2009: Rakha Emad A; El-Sayed Maysa E; Reed Jacquie; Lee Andrew H S; Evans Andrew J; Ellis Ian O
Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis).
European journal of cancer (Oxford, England : 1990) 2009;45(7):1162-7.
2009: Rakha Emad A; Elsheikh Somaia E; Aleskandarany Muhammed A; Habashi Hany O; Green Andrew R; Powe Desmond G; El-Sayed Maysa E; Benhasouna Ahmed; Brunet Jean-Sébastien; Akslen Lars A; Evans Andy J; Blamey Roger; Reis-Filho Jorge S; Foulkes William D; Ellis Ian O
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2302-10.
2009: Green Andrew R; Young Peter; Krivinskas Sophie; Rakha Emad A; Claire Paish E; Powe Desmond G; Ellis Ian O
The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Histopathology 2009;54(4):419-27.
2009: Rakha Emad A; Gill Muhammad S; El-Sayed Maysa E; Khan Marium M; Hodi Zsolt; Blamey Roger W; Evans Andrew J; Lee Andrew H S; Ellis Ian O
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.
Breast cancer research and treatment 2009;114(2):243-50.
2009: Rakha Emad A; El-Sayed Maysa E; Reis-Filho Jorge; Ellis Ian O
Patho-biological aspects of basal-like breast cancer.
Breast cancer research and treatment 2009;113(3):411-22.
2009: Mohammed Rabab A A; Ellis Ian O; Elsheikh Somaia; Paish Emma C; Martin Stewart G
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
Breast cancer research and treatment 2009;113(2):261-73.
2009: Pickard Mark R; Green Andrew R; Ellis Ian O; Caldas Carlos; Hedge Vanessa L; Mourtada-Maarabouni Mirna; Williams Gwyn T
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
Breast cancer research : BCR 2009;11(4):R60.
2008: Speirs Valerie; Green Andrew R; Hughes Thomas A; Ellis Ian O; Saunders Philippa T K; Shaaban Abeer M
Clinical importance of estrogen receptor beta isoforms in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5825; author reply 5825-6.
2008: Tennant S L; Evans A; Hamilton L J; James J; Lee A H S; Hodi Z; Ellis I O; Rakha E A; Wilson A R M
Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases.
Breast (Edinburgh, Scotland) 2008;17(6):546-9.
2008: Taneja S; Evans A J; Rakha E A; Green A R; Ball G; Ellis I O
The mammographic correlations of a new immunohistochemical classification of invasive breast cancer.
Clinical radiology 2008;63(11):1228-35.
2008: Spendlove Ian; Al-Attar Ahmad; Watherstone Oliver; Webb Thomas M; Ellis Ian O; Longmore Gregory D; Sharp Tyson V
Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival.
International journal of cancer. Journal international du cancer 2008;123(10):2247-53.
2008: El-Sayed Maysa E; Rakha Emad A; Reed Jacquie; Lee Andrew Hs; Evans Andrew J; Ellis Ian O
Audit of performance of needle core biopsy diagnoses of screen detected breast lesions.
European journal of cancer (Oxford, England : 1990) 2008;44(17):2580-6.
2008: Webster Lucy R; Lee Shu-Fen; Ringland Clare; Morey Adrienne L; Hanby Andrew M; Morgan Graeme; Byth Karen; Mote Patricia A; Provan Pamela J; Ellis Ian O; Green Andrew R; Lamoury Gillian; Ravdin Peter; Clarke Christine L; Ward Robyn L; Balleine Rosemary L; Hawkins Nicholas J
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6625-33.
2008: Cheung K L; Wong A W S; Parker H; Li V W Y; Winterbottom L; Morgan D A L; Ellis I O
Pathological features of primary breast cancer in the elderly based on needle core biopsies--a large series from a single centre.
Critical reviews in oncology/hematology 2008;67(3):263-7.
2008: Rakha Emad A; El-Sayed Maysa E; Menon Sindhu; Green Andrew R; Lee Andrew H S; Ellis Ian O
Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
Breast cancer research and treatment 2008;111(1):121-7.
2008: Shaaban Abeer M; Green Andrew R; Karthik Suchita; Alizadeh Yalda; Hughes Thomas A; Harkins Lynn; Ellis Ian O; Robertson John F; Paish Emma C; Saunders Philippa T K; Groome Nigel P; Speirs Valerie
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5228-35.
2008: Rakha Emad A; Ellis Ian O; Reis-Filho Jorge S
Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(8):1060-1; author reply 1061-2.
2008: Luck Angela A; Evans Andrew J; James Jonathan J; Rakha Emad A; Paish E Claire; Green Andrew R; Ellis Ian O
Breast carcinoma with basal phenotype: mammographic findings.
AJR. American journal of roentgenology 2008;191(2):346-51.
2008: Green Andrew R; Burney Claire; Granger Christopher J; Paish E Claire; El-Sheikh Somaia; Rakha Emad A; Powe Desmond G; Macmillan R Douglas; Ellis Ian O; Stylianou Eleni
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
Breast cancer research and treatment 2008;110(3):427-37.
2008: Habashy Hany Onsy; Powe Desmond G; Rakha Emad A; Ball Graham; Paish Claire; Gee Julia; Nicholson Robert I; Ellis Ian O
Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.
European journal of cancer (Oxford, England : 1990) 2008;44(11):1541-51.
2008: Rakha Emad A; El-Sayed Maysa E; Lee Andrew H S; Elston Christopher W; Grainge Matthew J; Hodi Zsolt; Blamey Roger W; Ellis Ian O
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3153-8.
2008: Lee Andrew H S; Ellis Ian O
The Nottingham prognostic index for invasive carcinoma of the breast.
Pathology oncology research : POR 2008;14(2):113-5.
2008: Rakha Emad A; El-Sheikh Somaia E; Kandil Mona A; El-Sayed Maysa E; Green Andrew R; Ellis Ian O
Expression of BRCA1 protein in breast cancer and its prognostic significance.
Human pathology 2008;39(6):857-65.
2008: Rakha Emad A; Reis-Filho Jorge S; Ellis Ian O
Basal-like breast cancer: a critical review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2568-81.
2008: Menon S; Porter G J R; Evans A J; Ellis I O; Elston C W; Hodi Z; Lee A H S
The significance of lobular neoplasia on needle core biopsy of the breast.
Virchows Archiv : an international journal of pathology 2008;452(5):473-9.
2008: Elsheikh Somaia; Green Andrew R; Aleskandarany Mohammed A; Grainge Matthew; Paish Claire E; Lambros Maryou B K; Reis-Filho Jorge S; Ellis Ian O
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Breast cancer research and treatment 2008;109(2):325-35.
2008: Abdel-Fatah Tarek M A; Powe Desmond G; Hodi Zsolt; Reis-Filho Jorge S; Lee Andrew H S; Ellis Ian O
Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
The American journal of surgical pathology 2008;32(4):513-23.
2008: Luck A A; Evans A J; Green A R; Rakha E A; Paish C; Ellis I O
The influence of basal phenotype on the metastatic pattern of breast cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2008;20(1):40-5.
2008: Rakha E A; El-Sayed M E; Reis-Filho J S; Ellis I O
Expression profiling technology: its contribution to our understanding of breast cancer.
Histopathology 2008;52(1):67-81.
2008: Rakha Emad A; El-Sayed Maysa E; Powe Desmond G; Green Andrew R; Habashy Hany; Grainge Matthew J; Robertson John F R; Blamey Roger; Gee Julia; Nicholson Robert I; Lee Andrew H S; Ellis Ian O
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
European journal of cancer (Oxford, England : 1990) 2008;44(1):73-83.
2008: Zhu XingWu; Mulcahy Lori A; Mohammed Rabab A A; Lee Andrew H S; Franks Hester A; Kilpatrick Laura; Yilmazer Acelya; Paish E Claire; Ellis Ian O; Patel Poulam M; Jackson Andrew M
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.
Breast cancer research : BCR 2008;10(6):R95.
2008: Cooke Susanna L; Pole Jessica C M; Chin Suet-Feung; Ellis Ian O; Caldas Carlos; Edwards Paul A W
High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.
BMC cancer 2008;8():288.
2008: Fanshawe Thomas R; Lynch Andrew G; Ellis Ian O; Green Andrew R; Hanka Rudolf
Assessing agreement between multiple raters with missing rating information, applied to breast cancer tumour grading.
PloS one 2008;3(8):e2925.
2008: Rakha Emad A; Reis-Filho Jorge S; Ellis Ian O
Impact of basal-like breast carcinoma determination for a more specific therapy.
Pathobiology : journal of immunopathology, molecular and cellular biology 2008;75(2):95-103.
2007: Mohammed Rabab A A; Martin Stewart G; Gill Muhammad S; Green Andrew R; Paish Emma C; Ellis Ian O
Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
The American journal of surgical pathology 2007;31(12):1825-33.
2007: Rakha E A; Ellis I O
An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.
Journal of clinical pathology 2007;60(12):1300-6.
2007: Wienke Dirk; Davies Gareth C; Johnson Damian A; Sturge Justin; Lambros Maryou B K; Savage Kay; Elsheikh Somaia Elbauomy; Green Andrew R; Ellis Ian O; Robertson David; Reis-Filho Jorge S; Isacke Clare M
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
Cancer research 2007;67(21):10230-40.
2007: Bartlett John M S; Ellis Ian O; Dowsett Mitch; Mallon Elizabeth A; Cameron David A; Johnston Stephen; Hall Emma; A'Hern Roger; Peckitt Clare; Bliss Judith M; Johnson Lindsay; Barrett-Lee Peter; Ellis Paul
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4423-30.
2007: Rakha Emad A; El-Sayed Maysa E; Green Andrew R; Paish E Claire; Powe Desmond G; Gee Julia; Nicholson Robert I; Lee Andrew H S; Robertson John F R; Ellis Ian O
Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4772-8.
2007: Mathew J; Asgeirsson K S; Agrawal A; Mukherjee A; Ellis I O; Cheung K L; Chan S Y; Robertson J F R
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(8):972-6.
2007: Taylor Kathryn M; Morgan Helen E; Smart Kathryn; Zahari Normawati M; Pumford Sara; Ellis Ian O; Robertson John F R; Nicholson Robert I
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer.
Molecular medicine (Cambridge, Mass.) 2007;13(7-8):396-406.
2007: Naderi Ali; Teschendorff Andrew E; Beigel Juergen; Cariati Massimiliano; Ellis Ian O; Brenton James D; Caldas Carlos
BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
Cancer research 2007;67(14):6725-36.
2007: Blamey R W; Ellis I O; Pinder S E; Lee A H S; Macmillan R D; Morgan D A L; Robertson J F R; Mitchell M J; Ball G R; Haybittle J L; Elston C W
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.
European journal of cancer (Oxford, England : 1990) 2007;43(10):1548-55.
2007: Blamey R W; Pinder S E; Ball G R; Ellis I O; Elston C W; Mitchell M J; Haybittle J L
Reading the prognosis of the individual with breast cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(10):1545-7.
2007: Mohammed R A A; Green A; El-Shikh S; Paish E C; Ellis I O; Martin S G
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.
British journal of cancer 2007;96(7):1092-100.
2007: Rakha E A; El-Sayed M E; Green A R; Paish E C; Lee A H S; Ellis I O
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.
Histopathology 2007;50(4):434-8.
2007: Rolland Phil; Madjd Zahra; Durrant Lindy; Ellis Ian O; Layfield Rob; Spendlove Ian
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease.
Endocrine-related cancer 2007;14(1):73-80.
2007: Abdel-Fatah Tarek M A; Powe Desmond G; Hodi Zsolt; Lee Andrew H S; Reis-Filho Jorge S; Ellis Ian O
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
The American journal of surgical pathology 2007;31(3):417-26.
2007: Rolland Phil; Spendlove Ian; Madjd Zahra; Rakha Emad A; Patel Poulam; Ellis Ian O; Durrant Lindy
The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.
International journal of cancer. Journal international du cancer 2007;120(6):1311-7.
2007: Naderi A; Teschendorff A E; Barbosa-Morais N L; Pinder S E; Green A R; Powe D G; Robertson J F R; Aparicio S; Ellis I O; Brenton J D; Caldas C
A gene-expression signature to predict survival in breast cancer across independent data sets.
Oncogene 2007;26(10):1507-16.
2007: Hodi Zsolt; Chakrabarti Jayeta; Lee Andrew H S; Ronan John E; Elston Christopher W; Cheung Kwok Leung; Robertson John F R; Ellis Ian O
The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.
Journal of clinical pathology 2007;60(3):299-302.
2007: Rakha Emad A; El-Sayed Maysa E; Green Andrew R; Lee Andrew H S; Robertson John F; Ellis Ian O
Prognostic markers in triple-negative breast cancer.
Cancer 2007;109(1):25-32.
2007: Rakha Emad A; Tan David S P; Foulkes William D; Ellis Ian O; Tutt Andrew; Nielsen Torsten O; Reis-Filho Jorge S
Are triple-negative tumours and basal-like breast cancer synonymous?
Breast cancer research : BCR 2007;9(6):404; author reply 405.
2007: Evans A J; Rakha E A; Pinder S E; Green A R; Paish C; Ellis I O
Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
Journal of medical screening 2007;14(4):210-4.
2007: Asgeirsson Kristjan S; Agrawal Amit; Allen Claire; Hitch Anthony; Ellis Ian O; Chapman Caroline; Cheung Kwok L; Robertson John F R
Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.
Breast cancer research : BCR 2007;9(6):R75.
2007: Chin Suet F; Teschendorff Andrew E; Marioni John C; Wang Yanzhong; Barbosa-Morais Nuno L; Thorne Natalie P; Costa Jose L; Pinder Sarah E; van de Wiel Mark A; Green Andrew R; Ellis Ian O; Porter Peggy L; Tavaré Simon; Brenton James D; Ylstra Bauke; Caldas Carlos
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
Genome biology 2007;8(10):R215.
2007: Blenkiron Cherie; Goldstein Leonard D; Thorne Natalie P; Spiteri Inmaculada; Chin Suet-Feung; Dunning Mark J; Barbosa-Morais Nuno L; Teschendorff Andrew E; Green Andrew R; Ellis Ian O; Tavaré Simon; Caldas Carlos; Miska Eric A
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
Genome biology 2007;8(10):R214.
2007: Hutcheson Iain R; Knowlden Janice M; Hiscox Steve E; Barrow Denise; Gee Julia M W; Robertson John F; Ellis Ian O; Nicholson Robert I
Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Breast cancer research : BCR 2007;9(4):R50.
2007: Teschendorff Andrew E; Miremadi Ahmad; Pinder Sarah E; Ellis Ian O; Caldas Carlos
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.
Genome biology 2007;8(8):R157.
2007: Elbauomy Elsheikh Somaia; Green Andrew R; Lambros Maryou B K; Turner Nicholas C; Grainge Matthew J; Powe Des; Ellis Ian O; Reis-Filho Jorge S
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.
Breast cancer research : BCR 2007;9(2):R23.
2006: Rakha Emad A; El-Rehim Dalia Abd; Paish Claire; Green Andrew R; Lee Andrew H S; Robertson John F; Blamey Roger W; Macmillan Douglas; Ellis Ian O
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
European journal of cancer (Oxford, England : 1990) 2006;42(18):3149-56.
2006: Evans Andrew J; Pinder Sarah E; James Jonathan J; Ellis Ian O; Cornford Eleanor
Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer?
AJR. American journal of roentgenology 2006;187(5):1377-80.
2006: Watson Nicholas F S; Durrant Lindy G; Scholefield John H; Madjd Zahra; Scrimgeour Duncan; Spendlove Ian; Ellis Ian O; Patel Poulam M
Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
World journal of gastroenterology : WJG 2006;12(39):6299-304.
2006: Watson Nicholas F S; Durrant Lindy G; Madjd Zahra; Ellis Ian O; Scholefield John H; Spendlove Ian
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
Cancer immunology, immunotherapy : CII 2006;55(8):973-80.
2006: Rakha Emad A; Green Andrew R; Powe Des G; Roylance Rebecca; Ellis Ian O
Chromosome 16 tumor-suppressor genes in breast cancer.
Genes, chromosomes & cancer 2006;45(6):527-35.
2006: Callagy Grace M; Pharoah Paul D; Pinder Sarah E; Hsu Forrest D; Nielsen Torsten O; Ragaz Joseph; Ellis Ian O; Huntsman David; Caldas Carlos
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2468-75.
2006: Rakha E A; Putti T C; Abd El-Rehim D M; Paish C; Green A R; Powe D G; Lee A H; Robertson J F; Ellis I O
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
The Journal of pathology 2006;208(4):495-506.
2006: Watson Nicholas F S; Spendlove Ian; Madjd Zahra; McGilvray Roger; Green Andrew R; Ellis Ian O; Scholefield John H; Durrant Lindy G
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.
International journal of cancer. Journal international du cancer 2006;118(6):1445-52.
2006: Ellis I O; Coleman D; Wells C; Kodikara S; Paish E M; Moss S; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly C E; Dallimore N S; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Parham D; Patnick J; Pinder S E; Quinn C M; Robertson A J; Shrimankar J; Walker R A; Winder R
Impact of a national external quality assessment scheme for breast pathology in the UK.
Journal of clinical pathology 2006;59(2):138-45.
2006: Parham D M; Coleman D; Kodikara S; Moss S; Ellis I O; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly C E; Dallimore N S; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Patnick J; Pinder S E; Quinn C M; Robertson A J; Shrimankar J; Walker R A; Wells C; Winder R; Patel N
The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal.
Journal of clinical pathology 2006;59(2):130-7.
2006: Lee A H S; Pinder S E; Macmillan R D; Mitchell M; Ellis I O; Elston C W; Blamey R W
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
European journal of cancer (Oxford, England : 1990) 2006;42(3):357-62.
2006: Asioli Sofia; Marucci Gianluca; Ficarra Guido; Stephens Mark; Foschini Maria P; Ellis Ian O; Eusebi Vincenzo
Polymorphous adenocarcinoma of the breast. Report of three cases.
Virchows Archiv : an international journal of pathology 2006;448(1):29-34.
2006: Watson Nicholas F S; Ramage Judith M; Madjd Zahra; Spendlove Ian; Ellis Ian O; Scholefield John H; Durrant Lindy G
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.
International journal of cancer. Journal international du cancer 2006;118(1):6-10.
2006: Teschendorff Andrew E; Naderi Ali; Barbosa-Morais Nuno L; Pinder Sarah E; Ellis Ian O; Aparicio Sam; Brenton James D; Caldas Carlos
A consensus prognostic gene expression classifier for ER positive breast cancer.
Genome biology 2006;7(10):R101.
2006: Porter Gareth J R; Evans A J; Burrell H C; Lee A H S; Ellis I O; Chakrabarti J
Interval breast cancers: prognostic features and survival by subtype and time since screening.
Journal of medical screening 2006;13(3):115-22.
2005: Putti T C; Pinder S E; Elston C W; Lee A H S; Ellis I O
Breast pathology practice: most common problems in a consultation service.
Histopathology 2005;47(5):445-57.
2005: Madjd Zahra; Spendlove Ian; Pinder Sarah E; Ellis Ian O; Durrant Lindy G
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
International journal of cancer. Journal international du cancer 2005;117(2):248-55.
2005: Rakha Emad A; Boyce Richard W G; Abd El-Rehim Dalia; Kurien Thomas; Green Andrew R; Paish Emma C; Robertson John F R; Ellis Ian O
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1295-304.
2005: Kurien T; Boyce R W G; Paish E C; Ronan J; Maddison J; Rakha E A; Green A R; Ellis I O
Three dimensional reconstruction of a human breast carcinoma using routine laboratory equipment and immunohistochemistry.
Journal of clinical pathology 2005;58(9):968-72.
2005: Abd El-Rehim Dalia M; Ball Graham; Pinder Sarah E; Rakha Emad; Paish Claire; Robertson John F R; Macmillan Douglas; Blamey Roger W; Ellis Ian O
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
International journal of cancer. Journal international du cancer 2005;116(3):340-50.
2005: Gee J M; Robertson J F; Gutteridge E; Ellis I O; Pinder S E; Rubini M; Nicholson R I
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.
Endocrine-related cancer 2005;12 Suppl 1():S99-S111.
2005: Watson Nicholas F S; Madjd Zahra; Scrimegour Duncan; Spendlove Ian; Ellis Ian O; Scholefield John H; Durrant Lindy G
Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.
World journal of surgical oncology 2005;3():47.
2005: Rakha E A; Abd El Rehim D; Pinder S E; Lewis S A; Ellis I O
E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Histopathology 2005;46(6):685-93.
2005: Simpson Peter T; Gale Theo; Reis-Filho Jorge S; Jones Chris; Parry Suzanne; Sloane John P; Hanby Andrew; Pinder Sarah E; Lee Andrew H S; Humphreys Steve; Ellis Ian O; Lakhani Sunil R
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.
The American journal of surgical pathology 2005;29(6):734-46.
2005: Sikand K; Lee A H S; Pinder S E; Elston C W; Ellis I O
Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value.
Journal of clinical pathology 2005;58(5):543-5.
2005: Rakha Emad A; Armour John A L; Pinder Sarah E; Paish Claire E; Ellis Ian O
High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.
International journal of cancer. Journal international du cancer 2005;114(5):720-9.
2005: Madjd Zahra; Durrant Lindy G; Pinder Sarah E; Ellis Ian O; Ronan John; Lewis Sarah; Rushmere Neil K; Spendlove Ian
Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?
Cancer immunology, immunotherapy : CII 2005;54(2):149-56.
2005: Putti Thomas C; El-Rehim Dalia M Abd; Rakha Emad A; Paish Claire E; Lee Andrew H S; Pinder Sarah E; Ellis Ian O
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):26-35.
2004: Anderson Thomas J; Waller Michael; Ellis Ian O; Bobrow Lynda; Moss Susan
Influence of annual mammography from age 40 on breast cancer pathology.
Human pathology 2004;35(10):1252-9.
2004: Abd El-Rehim D M; Pinder S E; Paish C E; Bell J A; Rampaul R S; Blamey R W; Robertson J F R; Nicholson R I; Ellis I O
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
British journal of cancer 2004;91(8):1532-42.
2004: Rakha E A; Pinder S E; Paish C E; Ellis I O
Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
British journal of cancer 2004;91(8):1591-6.
2004: Cid J A; Rampaul R S; Ellis I O; Wilson A R M; Burrell H C; Evans A J; Blamey R W; Macmillan R D
Woman feels breast lump--surgeon cannot: the role of ultrasound in arbitration.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2053-5.
2004: Ellis I O; Humphreys S; Michell M; Pinder S E; Wells C A; Zakhour H D;
Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.
Journal of clinical pathology 2004;57(9):897-902.
2004: Panigrahi A R; Pinder S E; Chan S Y; Paish E C; Robertson J F R; Ellis I O
The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
The Journal of pathology 2004;204(1):93-100.
2004: Rakha Emad A; Pinder Sarah E; Paish E Claire; Robertson John F; Ellis Ian O
Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
The Journal of pathology 2004;203(3):754-61.
2004: Abd El-Rehim Dalia M; Pinder Sarah E; Paish Claire E; Bell J; Blamey R W; Robertson John F R; Nicholson Robert I; Ellis Ian O
Expression of luminal and basal cytokeratins in human breast carcinoma.
The Journal of pathology 2004;203(2):661-71.
2004: Kollias J; Pinder S E; Denley H E; Ellis I O; Wencyk P; Bell J A; Elston C W; Blamey R W
Phenotypic similarities in bilateral breast cancer.
Breast cancer research and treatment 2004;85(3):255-61.
2004: Iau P T C; Marafie M; Ali A; Sng J H; Macmillan R D; Pinder S; Denley H E; Ellis I O; Wenzyck P; Scott N; Cross G; Blamey R W
Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.
Breast cancer research and treatment 2004;85(1):81-8.
2004: Madjd Zahra; Durrant Lindy G; Bradley Richard; Spendlove Ian; Ellis Ian O; Pinder Sarah E
Loss of CD55 is associated with aggressive breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2797-803.
2004: Rampaul Raj S; Pinder Sarah E; Wencyk Pete M; Nicholson Rob I; Blamey Roger W; Robertson John F; Ellis Ian O
Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2578.
2004: Ellis I O; Bartlett J; Dowsett M; Humphreys S; Jasani B; Miller K; Pinder S E; Rhodes A; Walker R
Best Practice No 176: Updated recommendations for HER2 testing in the UK.
Journal of clinical pathology 2004;57(3):233-7.
2004: Felton T; Harris G C; Pinder S E; Snead D R J; Carter G I; Bell J A; Haines A; Kollias J; Robertson J F R; Elston C W; Ellis I O
Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.
Breast (Edinburgh, Scotland) 2004;13(1):35-41.
2004: Di Tommaso Luca; Foschini Maria P; Ragazzini Teresa; Magrini Elisabetta; Fornelli Adele; Ellis Ian O; Eusebi Vincenzo
Mucoepidermoid carcinoma of the breast.
Virchows Archiv : an international journal of pathology 2004;444(1):13-9.
2003: Barnes A; Pinder S E; Bell J A; Paish E C; Wencyk P M; Robertson J F R; Elston C W; Ellis I O
Expression of p27kip1 in breast cancer and its prognostic significance.
The Journal of pathology 2003;201(3):451-9.
2003: Dunne Barbara; Lee Andrew H S; Pinder Sarah E; Bell Jane A; Ellis Ian O
An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
Human pathology 2003;34(10):1009-15.
2003: Damera A; Evans A J; Cornford E J; Wilson A R M; Burrell H C; James J J; Pinder S E; Ellis I O; Lee A H S; Macmillan R D
Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer.
British journal of cancer 2003;89(7):1310-3.
2003: Madjd Z; Pinder S E; Paish C; Ellis I O; Carmichael J; Durrant L G
Loss of CD59 expression in breast tumours correlates with poor survival.
The Journal of pathology 2003;200(5):633-9.
2003: Sawyer Elinor J; Hanby Andrew M; Poulsom Richard; Jeffery Rosemary; Gillett Cheryl E; Ellis Ian O; Ellis Paul; Tomlinson Ian P M
Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
The Journal of pathology 2003;200(5):627-32.
2003: Eusebi V; Damiani S; Ellis I O; Azzopardi J G; Rosai J
Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases.
The American journal of surgical pathology 2003;27(8):1114-8.
2003: Lambie H; Miremadi A; Pinder S E; Bell J A; Wencyk P; Paish E C; Macmillan R D; Ellis I O
Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
The Journal of pathology 2003;200(2):207-13.
2003: Sawyer Elinor J; Poulsom Richard; Hunt F Toby; Jeffery Rosemary; Elia George; Ellis Ian O; Ellis Paul; Tomlinson Ian P M; Hanby Andrew M
Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
The Journal of pathology 2003;200(1):59-64.
2003: Lee A H S; Denley H E; Pinder S E; Ellis I O; Elston C W; Vujovic P; Macmillan R D; Evans A J;
Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
Histopathology 2003;42(4):331-6.
2003: Dowsett M; Bartlett J; Ellis I O; Salter J; Hills M; Mallon E; Watters A D; Cooke T; Paish C; Wencyk P M; Pinder S E
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.
The Journal of pathology 2003;199(4):418-23.
2003: Bessell E M; Burton A; Haynes A P; Glaholm J; Child J A; Cullen M H; Davies J M; Smith G M; Ellis I O; Jack A; Jones E L;
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):258-67.
2003: James J J; Evans A J; Pinder S E; Macmillan R D; Wilson A R M; Ellis I O
Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?
Clinical radiology 2003;58(1):54-62.
2003: Harris Gavin C; Denley Helen E; Pinder Sarah E; Lee Andrew H S; Ellis Ian O; Elston Christopher W; Evans Andrew
Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma.
The American journal of surgical pathology 2003;27(1):11-5.
2003: Pinder Sarah E; Ellis Ian O
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Breast cancer research : BCR 2003;5(5):254-7.
2002: Elston C W; Ellis I O
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410.
Histopathology 2002;41(3A):151-2, discussion 152-3.
2002: Rampaul R S; Pinder S E; Gullick W J; Robertson J F R; Ellis I O
HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment.
Critical reviews in oncology/hematology 2002;43(3):231-44.
2002: Sawyer Elinor J; Hanby Andrew M; Rowan Andrew J; Gillett Cheryl E; Thomas Rachel E; Poulsom Richard; Lakhani Sunil R; Ellis Ian O; Ellis Paul; Tomlinson Ian P M
The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
The Journal of pathology 2002;196(4):437-44.
2002: Anderson Thomas J; Sufi Farzana; Ellis Ian O; Sloane John P; Moss Susan
Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years.
Human pathology 2002;33(3):365-71.
2002: Miremadi A; Pinder S E; Lee A H S; Bell J A; Paish E C; Wencyk P; Elston C W; Nicholson R I; Blamey R W; Robertson J F; Ellis I O
Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Histopathology 2002;40(3):215-22.
2001: Bagnall M J; Evans A J; Wilson A R; Pinder S E; Denley H; Geraghty J G; Ellis I O
Predicting invasion in mammographically detected microcalcification.
Clinical radiology 2001;56(10):828-32.
2001: Kollias J; Ellis I O; Elston C W; Blamey R W
Prognostic significance of synchronous and metachronous bilateral breast cancer.
World journal of surgery 2001;25(9):1117-24.
2001: Deb R A; Matthews P; Elston C W; Ellis I O; Pinder S E
An audit of "equivocal" (C3) and "suspicious" (C4) categories in fine needle aspiration cytology of the breast.
Cytopathology : official journal of the British Society for Clinical Cytology 2001;12(4):219-26.
2001: Thomson J Z; Evans A J; Pinder S E; Burrell H C; Wilson A R; Ellis I O
Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings.
British journal of cancer 2001;85(2):225-7.
2001: Gee J M; Robertson J F; Ellis I O; Nicholson R I
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.
International journal of cancer. Journal international du cancer 2001;95(4):247-54.
2001: Macmillan R D; Barbera D; Hadjiminas D J; Rampaul R S; Lee A H; Pinder S E; Ellis I O; Blamey R W; Geraghty J G
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study.
European journal of cancer (Oxford, England : 1990) 2001;37(9):1076-80.
2001: Kenny F S; Gee J M; Nicholson R I; Ellis I O; Morris T M; Watson S A; Bryce R P; Robertson J F
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts.
International journal of cancer. Journal international du cancer 2001;92(3):342-7.
2001: Wahedna Y; Evans A J; Pinder S E; Ellis I O; Blamey R W; Geraghty J G
Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
European journal of cancer (Oxford, England : 1990) 2001;37(4):459-62.
2001: Denley H; Pinder S E; Elston C W; Lee A H; Ellis I O
Preoperative assessment of prognostic factors in breast cancer.
Journal of clinical pathology 2001;54(1):20-4.
2001: Kenny F S; Willsher P C; Gee J M; Nicholson R; Pinder S E; Ellis I O; Robertson J F
Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer.
Breast cancer research and treatment 2001;65(2):135-44.
2001: Evans A J; Pinder S E; Ellis I O; Wilson A R
Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
Journal of medical screening 2001;8(3):149-51.
2001: Evans A J; Pinder S E; Burrell H C; Ellis I O; Wilson A R
Detecting which invasive cancers at mammographic screening saves lives?
Journal of medical screening 2001;8(2):86-90.
2001: Rampaul R S; Miremadi A; Pinder S E; Lee A; Ellis I O
Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer.
Breast cancer research : BCR 2001;3(2):113-6.
2000: Ellis I O; Dowsett M; Bartlett J; Walker R; Cooke T; Gullick W; Gusterson B; Mallon E; Lee P B
Recommendations for HER2 testing in the UK.
Journal of clinical pathology 2000;53(12):890-2.
2000: Kollias J; Man S; Marafie M; Carpenter K; Pinder S; Ellis I O; Blamey R W; Cross G; Brook J D
Loss of heterozygosity in bilateral breast cancer.
Breast cancer research and treatment 2000;64(3):241-51.
2000: Deb R A; Pinder S E; Lee A H; Ellis I O
Educational case report. Cohesive cells in a breast fine needle aspirate.
Cytopathology : official journal of the British Society for Clinical Cytology 2000;11(5):343-7.
2000: Bagnall M J; Evans A J; Wilson A R; Burrell H; Pinder S E; Ellis I O
When have mammographic calcifications been adequately sampled at needle core biopsy?
Clinical radiology 2000;55(7):548-53.
2000: Teh W L; Wilson A R; Evans A J; Burrell H; Pinder S E; Ellis I O
Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound.
Clinical radiology 2000;55(5):390-4.
2000: Whitlock J P; Evans A J; Burrell H C; Pinder S E; Ellis I O; Blamey R W; Wilson A R
Digital imaging improves upright stereotactic core biopsy of mammographic microcalcifications.
Clinical radiology 2000;55(5):374-7.
2000: Knowlden J M; Gee J M; Robertson J F; Ellis I O; Nicholson R I
A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer.
International journal of cancer. Journal international du cancer 2000;89(2):209-12.
2000: Gee J M; Barroso A F; Ellis I O; Robertson J F; Nicholson R I
Biological and clinical associations of c-jun activation in human breast cancer.
International journal of cancer. Journal international du cancer 2000;89(2):177-86.
2000: Kew T Y; Bell J A; Pinder S E; Denley H; Srinivasan R; Gullick W J; Nicholson R I; Blamey R W; Ellis I O
c-erbB-4 protein expression in human breast cancer.
British journal of cancer 2000;82(6):1163-70.
2000: Sawyer E J; Hanby A M; Ellis P; Lakhani S R; Ellis I O; Boyle S; Tomlinson I P
Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.
The American journal of pathology 2000;156(3):1093-8.
2000: Kenny F S; Pinder S E; Ellis I O; Gee J M; Nicholson R I; Bryce R P; Robertson J F
Gamma linolenic acid with tamoxifen as primary therapy in breast cancer.
International journal of cancer. Journal international du cancer 2000;85(5):643-8.
2000: Denley H; Pinder S E; Tan P H; Sim C S; Brown R; Barker T; Gearty J; Elston C W; Ellis I O
Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases.
Histopathology 2000;36(3):203-9.
2000: Lee A H; Ellis I O; Pinder S E; Barbera D; Elston C W
Pathological assessment of sentinel lymph-node biopsies in patients with breast cancer.
Virchows Archiv : an international journal of pathology 2000;436(2):97-101.
1999: Evans A J; Whitlock J P; Burrell H C; Pinder S E; Ellis I O; Geraghty J G; Lee A H; Wilson A R
A comparison of 14 and 12 gauge needles for core biopsy of suspicious mammographic calcification.
The British journal of radiology 1999;72(864):1152-4.
1999: Gee J M; Robertson J F; Ellis I O; Nicholson R I; Hurst H C
Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
The Journal of pathology 1999;189(4):514-20.
1999: Kollias J; Ellis I O; Elston C W; Blamey R W
Clinical and histological predictors of contralateral breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999;25(6):584-9.
1999: Ellis I O; Lee A H; Elston C W; Pinder S E
Microinvasive carcinoma of the breast: diagnostic criteria and clinical relevance.
Histopathology 1999;35(5):470-2.
1999: Bessell E M; Selby C; Ellis I O
Severe hypoglycaemia caused by raised insulin-like growth factor II in disseminated breast cancer.
Journal of clinical pathology 1999;52(10):780-1.
1999: Evans A J; Wilson A R; Burrell H C; Ellis I O; Pinder S E
Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography.
Clinical radiology 1999;54(10):644-6.
1999: Elston C W; Ellis I O; Pinder S E
Pathological prognostic factors in breast cancer.
Critical reviews in oncology/hematology 1999;31(3):209-23.
1999: Ellis I O; Pinder S E; Lee A H; Elston C W
A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?
Seminars in diagnostic pathology 1999;16(3):202-8.
1999: Hall N J; Evans A J; Kollias J; Denley H; Pinder S E; Ellis I O; Blamey R W; Wilson A R
Bilateral breast carcinomas: do they have similar mammographic features?
Clinical radiology 1999;54(7):434-7.
1999: Kollias J; Murphy C A; Elston C W; Ellis I O; Robertson J F; Blamey R W
The prognosis of small primary breast cancers.
European journal of cancer (Oxford, England : 1990) 1999;35(6):908-12.
1999: McClelland R A; Gee J M; O'Sullivan L; Barnes D M; Robertson J F; Ellis I O; Nicholson R I
p21(WAF1) expression and endocrine response in breast cancer.
The Journal of pathology 1999;188(2):126-32.
1999: Seery L T; Knowlden J M; Gee J M; Robertson J F; Kenny F S; Ellis I O; Nicholson R I
BRCA1 expression levels predict distant metastasis of sporadic breast cancers.
International journal of cancer. Journal international du cancer 1999;84(3):258-62.
1999: Gonzalez M A; Pinder S E; Wencyk P M; Bell J A; Elston C W; Nicholson R I; Robertson J F; Blamey R W; Ellis I O
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
The Journal of pathology 1999;187(5):523-9.
1999: Gee J M; Willsher P C; Kenny F S; Robertson J F; Pinder S E; Ellis I O; Nicholson R I
Endocrine response and resistance in breast cancer: a role for the transcription factor Fos.
International journal of cancer. Journal international du cancer 1999;84(1):54-61.
1998: Kamal M; Evans A J; Denley H; Pinder S E; Ellis I O
Fibroadenomatoid hyperplasia: a cause of suspicious microcalcification on mammographic screening.
AJR. American journal of roentgenology 1998;171(5):1331-4.
1998: Bessell E M; Moloney A J; Ellis I O; Fletcher J; Dowling F
Prognostic factors affecting disease-free survival in patients with Hodgkin's disease stages IA and IIA treated initially with radiotherapy alone in a single centre during 1973 to 1992.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;49(1):15-9.
1998: Knowlden J M; Gee J M; Seery L T; Farrow L; Gullick W J; Ellis I O; Blamey R W; Robertson J F; Nicholson R I
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer.
Oncogene 1998;17(15):1949-57.
1998: Willsher P C; Pinder S E; Gee J M; Ellis I O; Chan S Y; Nicholson R I; Blamey R W; Robertson J F
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.
Anticancer research 1998;18(5B):3695-8.
1998: Badve S; A'Hern R P; Ward A M; Millis R R; Pinder S E; Ellis I O; Gusterson B A; Sloane J P
Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.
Human pathology 1998;29(9):915-23.
1998: Lister D; Evans A J; Burrell H C; Blamey R W; Wilson A R; Pinder S E; Ellis I O; Elston C W; Kollias J
The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumps.
Clinical radiology 1998;53(7):490-2.
1998: Kollias J; Sibbering D M; Blamey R W; Holland P A; Obuszko Z; Wilson A R; Evans A J; Ellis I O; Elston C W
Screening women aged less than 50 years with a family history of breast cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(6):878-83.
1998: McClelland R A; Manning D L; Gee J M; Willsher P; Robertson J F; Ellis I O; Blamey R W; Nicholson R I
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
British journal of cancer 1998;77(10):1653-6.
1997: Knowlden J M; Gee J M; Bryant S; McClelland R A; Manning D L; Mansel R; Ellis I O; Blamey R W; Robertson J F; Nicholson R I
Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):2165-72.
1997: McCulloch G L; Evans A J; Yeoman L; Wilson A R; Pinder S E; Ellis I O; Elston C W
Radiological features of papillary carcinoma of the breast.
Clinical radiology 1997;52(11):865-8.
1997: Cheung K L; Willsher P C; Pinder S E; Ellis I O; Elston C W; Nicholson R I; Blamey R W; Robertson J F
Predictors of response to second-line endocrine therapy for breast cancer.
Breast cancer research and treatment 1997;45(3):219-24.
1997: Cheung K L; Blamey R W; Robertson J F; Elston C W; Ellis I O
Subcutaneous mastectomy for primary breast cancer and ductal carcinoma in situ.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1997;23(4):343-7.
1997: Snead D R; Vryenhoef P; Pinder S E; Evans A; Wilson A R; Blamey R W; Elston C W; Ellis I O
Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates.
Cytopathology : official journal of the British Society for Clinical Cytology 1997;8(4):236-47.
1997: Willsher P C; Leach I H; Ellis I O; Bell J A; Elston C W; Bourke J B; Blamey R W; Robertson J F
Male breast cancer: pathological and immunohistochemical features.
Anticancer research 1997;17(3C):2335-8.
1997: Willsher P C; Leach I H; Ellis I O; Bourke J B; Blamey R W; Robertson J F
A comparison outcome of male breast cancer with female breast cancer.
American journal of surgery 1997;173(3):185-8.
1997: Kollias J; Elston C W; Ellis I O; Robertson J F; Blamey R W
Early-onset breast cancer--histopathological and prognostic considerations.
British journal of cancer 1997;75(9):1318-23.
1997: Evans A J; Pinder S E; Snead D R; Wilson A R; Ellis I O; Elston C W
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours.
British journal of cancer 1997;75(4):542-4.
1997: Hewitt R E; Powe D G; Morrell K; Balley E; Leach I H; Ellis I O; Turner D R
Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast.
British journal of cancer 1997;75(2):221-9.
1996: Hunt C M; Wilson S; Pinder S E; Elston C W; Ellis I O
UK national audit of breast fine needle aspiration cytology in 1990-91: diagnostic criteria.
Cytopathology : official journal of the British Society for Clinical Cytology 1996;7(5):326-32.
1996: Hunt C M; Wilson S; Pinder S E; Elston C W; Ellis I O
United Kingdom national audit of breast fine needle aspiration cytology in 1990-91--organization and level of activity.
Cytopathology : official journal of the British Society for Clinical Cytology 1996;7(5):316-25.
1996: Matthews P; Ellis I O
Use of immunocytochemistry in the diagnosis of metastatic carcinoma.
Annals of medicine 1996;28(4):297-300.
1996: Litherland J C; Evans A J; Wilson A R; Kollias J; Pinder S E; Elston C W; Ellis I O; Yeoman L J
The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers.
Clinical radiology 1996;51(8):562-5.
1996: Travis A; Pinder S E; Robertson J F; Bell J A; Wencyk P; Gullick W J; Nicholson R I; Poller D N; Blamey R W; Elston C W; Ellis I O
C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
British journal of cancer 1996;74(2):229-33.
1996: Pinder S E; Elston C W; Ellis I O
The role of pre-operative diagnosis in breast cancer.
Histopathology 1996;28(6):563-6.
1996: Chopra S; Evans A J; Pinder S E; Yeoman L J; Ellis I O; Elston C W; Wilson A R
Pure mucinous breast cancer-mammographic and ultrasound findings.
Clinical radiology 1996;51(6):421-4.
1996: Burrell H C; Sibbering D M; Wilson A R; Pinder S E; Evans A J; Yeoman L J; Elston C W; Ellis I O; Blamey R W; Robertson J F
Screening interval breast cancers: mammographic features and prognosis factors.
Radiology 1996;199(3):811-7.
1996: Burrell H C; Pinder S E; Wilson A R; Evans A J; Yeoman L J; Elston C W; Ellis I O
The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesions.
Clinical radiology 1996;51(4):277-81.
1996: Willsher P C; Pinder S E; Robertson L; Nicholson R I; Ellis I O; Bell J A; Blamey R W; Green J A; Robertson J F
The significance of p53 autoantibodies in the serum of patients with breast cancer.
Anticancer research 1996;16(2):927-30.
1996: Ceccherini A F; Evans A J; Pinder S E; Wilson A R; Ellis I O; Yeoman L J
Is ipsilateral mammography worthwhile in Paget's disease of the breast?
Clinical radiology 1996;51(1):35-8.
1996: Willsher P C; Beaver J; Pinder S; Bell J A; Ellis I O; Blamey R W; Robertson J F
Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
Breast cancer research and treatment 1996;40(3):251-5.
1995: Sibbering D M; Galea M H; Morgan D A; Elston C W; Ellis I O; Robertson J F; Blamey R W
Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2191-5.
1995: Gee J M; Douglas-Jones A; Hepburn P; Sharma A K; McClelland R A; Ellis I O; Nicholson R I
A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
The Journal of pathology 1995;177(3):285-93.
1995: Pinder S E; Ellis I O; Elston C W
Prognostic factors in primary breast carcinoma.
Journal of clinical pathology 1995;48(11):981-3.
1995: Goulding H; Abdul Rashid N F; Robertson J F; Bell J A; Elston C W; Blamey R W; Ellis I O
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?
Human pathology 1995;26(11):1196-200.
1995: Archer S G; Eliopoulos A; Spandidos D; Barnes D; Ellis I O; Blamey R W; Nicholson R I; Robertson J F
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
British journal of cancer 1995;72(5):1259-66.
1995: Pinder S E; Wencyk P M; Naylor H E; Bell J A; Elston C W; Robertson J F; Blamey R W; Ellis I O
The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations.
Cytopathology : official journal of the British Society for Clinical Cytology 1995;6(5):316-24.
1995: Pereira H; Pinder S E; Sibbering D M; Galea M H; Elston C W; Blamey R W; Robertson J F; Ellis I O
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.
Histopathology 1995;27(3):219-26.
1995: Moffat C J; Pinder S E; Dixon A R; Elston C W; Blamey R W; Ellis I O
Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases.
Histopathology 1995;27(3):205-18.
1995: Gee J M; Ellis I O; Robertson J F; Willsher P; McClelland R A; Hewitt K N; Blamey R W; Nicholson R I
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.
International journal of cancer. Journal international du cancer 1995;64(4):269-73.
1995: Cornford E J; Wilson A R; Athanassiou E; Galea M; Ellis I O; Elston C W; Blamey R W
Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis.
The British journal of radiology 1995;68(809):450-3.
1995: Morris E S; Elston C W; Bell J A; Galea M; Blamey R W; Ellis I O
An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast.
The Journal of pathology 1995;176(1):55-62.
1995: Pinder S E; Wencyk P; Sibbering D M; Bell J A; Elston C W; Nicholson R; Robertson J F; Blamey R W; Ellis I O
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.
British journal of cancer 1995;71(1):146-9.
1995: O'Donoghue A E; Poller D N; Bell J A; Galea M H; Elston C W; Blamey R W; Ellis I O
Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.
Breast cancer research and treatment 1995;33(2):137-45.
1994: Gee J M; Robertson J F; Ellis I O; Willsher P; McClelland R A; Hoyle H B; Kyme S R; Finlay P; Blamey R W; Nicholson R I
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.
International journal of cancer. Journal international du cancer 1994;59(5):619-28.
1994: Spencer N J; Evans A J; Galea M; Sibbering D M; Yeoman L J; Pinder S E; Ellis I O; Elston C W; Blamey R W; Robertson J F
Pathological-radiological correlations in benign lesions excised during a breast screening programme.
Clinical radiology 1994;49(12):853-6.
1994: Pinder S E; Balsitis M; Ellis I O; Landon M; Mayer R J; Lowe J
The expression of alpha B-crystallin in epithelial tumours: a useful tumour marker?
The Journal of pathology 1994;174(3):209-15.
1994: Stutz J A; Evans A J; Pinder S; Ellis I O; Yeoman L J; Wilson A R; Sibbering D M
The radiological appearances of invasive cribriform carcinoma of the breast. Nottingham Breast Team.
Clinical radiology 1994;49(10):693-5.
1994: Evans A J; Pinder S E; Ellis I O; Sibbering D M; Elston C W; Poller D N; Wilson A R
Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.
Clinical radiology 1994;49(8):559-62.
1994: Nicholson R I; McClelland R A; Gee J M; Manning D L; Cannon P; Robertson J F; Ellis I O; Blamey R W
Transforming growth factor-alpha and endocrine sensitivity in breast cancer.
Cancer research 1994;54(7):1684-9.
1994: Evans A J; Pinder S; Ellis I O; Sibbering M; Elston C W; Poller D N; Wilson R
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
Radiology 1994;191(1):237-40.
1994: Poller D N; Silverstein M J; Galea M; Locker A P; Elston C W; Blamey R W; Ellis I O
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(2):257-62.
1994: Pinder S E; Ellis I O; Galea M; O'Rouke S; Blamey R W; Elston C W
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.
Histopathology 1994;24(1):41-7.
1994: Nicholson R I; McClelland R A; Gee J M; Manning D L; Cannon P; Robertson J F; Ellis I O; Blamey R W
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Breast cancer research and treatment 1994;29(1):117-25.
1994: Manning D L; Robertson J F; Ellis I O; Elston C W; McClelland R A; Gee J M; Jones R J; Green C D; Cannon P; Blamey R W
Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):675-8.
1994: Robertson J F; Ellis I O; Pearson D; Elston C W; Nicholson R I; Blamey R W
Biological factors of prognostic significance in locally advanced breast cancer.
Breast cancer research and treatment 1994;29(3):259-64.
1994: Bessell E M; Coutts A; Fletcher J; Toghill P J; Moloney A J; Ellis I O; Hulman G; Jenkins D
Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1337-41.
1993: Cannon P M; Ellis I O; Blamey R W; Bell J; Elston C W; Robertson J F
Expression of tumour-associated antigens in breast cancer primary tissue compared with serum levels.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1993;19(6):523-7.
1993: Snead D R; Bell J A; Dixon A R; Nicholson R I; Elston C W; Blamey R W; Ellis I O
Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: a comparison with frozen section methodology.
Histopathology 1993;23(3):233-8.
1993: Poller D N; Snead D R; Roberts E C; Galea M; Bell J A; Gilmour A; Elston C W; Blamey R W; Ellis I O
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
British journal of cancer 1993;68(1):156-61.
1993: Poller D N; Roberts E C; Bell J A; Elston C W; Blamey R W; Ellis I O
p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.
Human pathology 1993;24(5):463-8.
1993: Gamble A R; Bell J A; Ronan J E; Pearson D; Ellis I O
Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.
BMJ (Clinical research ed.) 1993;306(6873):295-8.
1993: Nicholson R I; McClelland R A; Finlay P; Eaton C L; Gullick W J; Dixon A R; Robertson J F; Ellis I O; Blamey R W
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):1018-23.
1992: Poller D N; Hutchings C E; Galea M; Bell J A; Nicholson R A; Elston C W; Blamey R W; Ellis I O
p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
British journal of cancer 1992;66(3):583-8.
1992: Dixon A R; Bell J; Ellis I O; Elston C W; Blamey R W
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
British journal of cancer 1992;66(3):537-41.
1992: Ellis I O; Galea M; Broughton N; Locker A; Blamey R W; Elston C W
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.
Histopathology 1992;20(6):479-89.
1992: Sacks N P; Robertson J F; Ellis I O; Nicholson R I; Crocker J; Blamey R W
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(2):98-102.
1992: Hitchcock A; Topham S; Bell J; Gullick W; Elston C W; Ellis I O
Routine diagnosis of mammary Paget's disease. A modern approach.
The American journal of surgical pathology 1992;16(1):58-61.
1992: Robertson J F; Ellis I O; Elston C W; Blamey R W
Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):908-10.
1992: Robertson J F; Dixon A R; Nicholson R I; Ellis I O; Elston C W; Blamey R W
Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.
Breast cancer research and treatment 1992;22(3):221-7.
1992: Galea M H; Blamey R W; Elston C E; Ellis I O
The Nottingham Prognostic Index in primary breast cancer.
Breast cancer research and treatment 1992;22(3):207-19.
1991: Poller D N; Galea M; Pearson D; Bell J; Gullick W J; Elston C W; Blamey R W; Ellis I O
Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.
Breast cancer research and treatment 1991;20(1):3-10.
1991: Bessell E M; MacLennan K A; Toghill P J; Ellis I O; Fletcher J; Dowling F D
Suprahyoid Hodgkin's disease stage IA.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;22(3):190-4.
1991: Elston C W; Ellis I O
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
Histopathology 1991;19(5):403-10.
1991: Galea M H; Athanassiou E; Bell J; Dilks B; Robertson J F; Elston C W; Blamey R W; Ellis I O
Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
The Journal of pathology 1991;165(3):221-7.
1991: Quincey C; Raitt N; Bell J; Ellis I O
Intracytoplasmic lumina--a useful diagnostic feature of adenocarcinomas.
Histopathology 1991;19(1):83-7.
1991: Dixon A R; Galea M H; Ellis I O; Elston C W; Blamey R W
Paget's disease of the nipple.
The British journal of surgery 1991;78(6):722-3.
1991: du Toit R S; Locker A P; Ellis I O; Elston C W; Nicholson R I; Robertson J F; Blamey R W
An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1991;17(3):251-7.
1991: Ellis I O
Practical application of determinants of cell behaviour.
British medical bulletin 1991;47(2):324-42.
1991: Dixon A R; Ellis I O; Elston C W; Blamey R W
A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
British journal of cancer 1991;63(4):634-5.
1991: Lovekin C; Ellis I O; Locker A; Robertson J F; Bell J; Nicholson R; Gullick W J; Elston C W; Blamey R W
c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
British journal of cancer 1991;63(3):439-43.
1991: Hitchcock A; Hunt C M; Locker A; Koslowski J; Strudwick S; Elston C W; Blamey R W; Ellis I O
A one year audit of fine needle aspiration cytology for the pre-operative diagnosis of breast disease.
Cytopathology : official journal of the British Society for Clinical Cytology 1991;2(4):167-76.
1991: Nicholson R I; Bouzubar N; Walker K J; McClelland R; Dixon A R; Robertson J F; Ellis I O; Blamey R W
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation.
European journal of cancer (Oxford, England : 1990) 1991;27(7):908-13.
1990: Arthur J E; Ellis I O; Flowers C; Roebuck E; Elston C W; Blamey R W
The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast.
The British journal of radiology 1990;63(755):845-9.
1990: Locker A P; Hanley P; Wilson A R; Roebuck E J; Morgan D A; Ellis I O; Elston C W; Blamey R W
Mammography in the pre-operative assessment and post-operative surveillance of patients treated by excision and radiotherapy for primary breast cancer.
Clinical radiology 1990;41(6):388-91.
1990: Lewis S; Locker A; Todd J H; Bell J A; Nicholson R; Elston C W; Blamey R W; Ellis I O
Expression of epidermal growth factor receptor in breast carcinoma.
Journal of clinical pathology 1990;43(5):385-9.
1990: Locker A P; Horrocks C; Gilmour A S; Ellis I O; Dowle C S; Elston C W; Blamey R W
Flow cytometric and histological analysis of ductal carcinoma in situ of the breast.
The British journal of surgery 1990;77(5):564-7.
1990: Shorrock K; Ellis I O; Finch R G
T-cell lymphoma associated with human immunodeficiency virus (HIV) infection.
Histopathology 1990;16(2):189-91.
1990: Du Toit R S; Locker A P; Ellis I O; Elston C W; Blamey R W
Evaluation of the prognostic value of triple node biopsy in early breast cancer.
The British journal of surgery 1990;77(2):163-7.
1990: Elston C W; Ellis I O
Pathology and breast screening.
Histopathology 1990;16(2):109-18.
1990: Hunt C M; Ellis I O; Elston C W; Locker A; Pearson D; Blamey R W
Cytological grading of breast carcinoma--a feasible proposition?
Cytopathology : official journal of the British Society for Clinical Cytology 1990;1(5):287-95.
1989: Locker A P; Dowle C S; Ellis I O; Elston C W; Blamey R W; Sikora K; Evan G; Robins R A
c-myc oncogene product expression and prognosis in operable breast cancer.
British journal of cancer 1989;60(5):669-72.
1989: Locker A P; Dilks B; Ellis I O; Elston C W; Blamey R W
DNA ploidy in fibroadenomas (abstract).
British journal of clinical practice. Supplement 1989;68():150; discussion 157-8.
1989: Robertson J F; Galea M H; Ellis I O; Elston C W; Blamey R W
Granulomatous mastitis.
British journal of clinical practice. Supplement 1989;68():143; discussion 157-8.
1989: du Toit R S; Locker A P; Ellis I O; Elston C W; Nicholson R I; Blamey R W
Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.
British journal of cancer 1989;60(4):605-9.
1989: Robertson J F; Ellis I O; Bell J; Todd J H; Robins A; Elston C W; Blamey R W
Carcinoembryonic antigen immunocytochemistry in primary breast cancer.
Cancer 1989;64(8):1638-45.
1989: Hitchcock A; Ellis I O; Robertson J F; Gilmour A; Bell J; Elston C W; Blamey R W
An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
The Journal of pathology 1989;159(2):129-34.
1989: Locker A P; Ellis I O; Morgan D A; Elston C W; Mitchell A; Blamey R W
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer.
The British journal of surgery 1989;76(9):890-4.
1989: Hitchcock A; Ellis I O; Bell J; Robins A
An investigation of NCRC11 immunoreactivity in normal and neoplastic epithelia of the female genital tract and ovary.
Histopathology 1989;15(2):187-94.
1989: Howard P W; Locker A P; Dowle C S; Ellis I O; Elston C W; Blamey R W
In situ carcinoma of the breast.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1989;15(4):328-32.
1989: Galea M H; Robertson J F; Ellis I O; Elston C W; Blamey R W
Granulomatous lobular mastitis.
The Australian and New Zealand journal of surgery 1989;59(7):547-50.
1989: Bouzubar N; Walker K J; Griffiths K; Ellis I O; Elston C W; Robertson J F; Blamey R W; Nicholson R I
Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
British journal of cancer 1989;59(6):943-7.
1988: Walker K J; Bouzubar N; Robertson J; Ellis I O; Elston C W; Blamey R W; Wilson D W; Griffiths K; Nicholson R I
Immunocytochemical localization of estrogen receptor in human breast tissue.
Cancer research 1988;48(22):6517-22.
1988: Ellis I O; Hitchcock A
Tumour marker immunoreactivity in adenocarcinoma.
Journal of clinical pathology 1988;41(10):1064-7.
1988: Robertson J F; Todd J H; Ellis I O; Elston C W; Blamey R W
Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.
BMJ (Clinical research ed.) 1988;297(6647):511-4.
1988: Locker A P; Galea M H; Ellis I O; Holliday H W; Elston C W; Blamey R W
Microdochectomy for single-duct discharge from the nipple.
The British journal of surgery 1988;75(7):700-1.
1988: Williamson K; Robertson J F; Ellis I O; Elston C W; Nicholson R I; Blamey R W
Effect of LHRH agonist, Zoladex, on ovarian histology.
The British journal of surgery 1988;75(6):595-6.
1987: Todd J H; Dowle C; Williams M R; Elston C W; Ellis I O; Hinton C P; Blamey R W; Haybittle J L
Confirmation of a prognostic index in primary breast cancer.
British journal of cancer 1987;56(4):489-92.
1987: Owainati A A; Robins R A; Hinton C; Ellis I O; Dowle C S; Ferry B; Elston C W; Blamey R W; Baldwin R W
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
British journal of cancer 1987;55(4):449-54.
1987: Dowle C S; Owainati A; Robins A; Burns K; Ellis I O; Elston C W; Blamey R W
Prognostic significance of the DNA content of human breast cancer.
The British journal of surgery 1987;74(2):133-6.
1987: Williams M R; Todd J H; Ellis I O; Dowle C S; Haybittle J L; Elston C W; Nicholson R I; Griffiths K; Blamey R W
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
British journal of cancer 1987;55(1):67-73.
1985: Ellis I O; Hinton C P; MacNay J; Elston C W; Robins A; Owainati A A; Blamey R W; Baldwin R W; Ferry B
Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.
British medical journal (Clinical research ed.) 1985;290(6472):881-3.
1984: Ellis I O; Robins R A; Elston C W; Blamey R W; Ferry B; Baldwin R W
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization.
Histopathology 1984;8(3):501-16.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ian Ellis

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ian Ellis (preview)

All Publications